US 7,609,767

Application 10/379,079 · Granted Oct 27, 2009

Signaling for fading compensation

Estimated expiration

August 9, 2027

260 days remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Mar 3, 2003
+ 20 years
Mar 3, 2023
PTA +1620d
Aug 9, 2027
No TD
—
Final
Aug 9, 2027

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 3, 2003
Earliest effective filing
March 3, 2003
Issue date
October 27, 2009
PTA
+1620 days
Base expiry (before PTA)
March 3, 2023

March 3, 2003 + 20 years = March 3, 2023 + 1620 PTA days = August 9, 2027

  • PRO60/377,628 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 10/379,079 · US 7,609,767

PatentReply compiles the prosecution history behind US 7,609,767: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US7609767

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.